Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in 'early stage'

Aurobindo Pharma Exclusive: CFO says Zentiva fits into strategic plans, but talks in 'early stage'Aurobindo Pharma CFO Santhanam Subramanian said that while Zentiva fits into Aurobindo Pharma's strategic plans as it is based out of Europe, it is too premature to comment on a possible outcome due to the early stages of the discussion.By Ekta Batra | Prashant Nair | Surabhi Upadhyay | Nigel D'Souza August 21, 2025, 9:08:03 AM IST (Published)1 Min ReadAurobindo Pharma Ltd. has entered into a Non Disclosure and Confidentiality agreement for its potential acquisition of Zentiva and talks are currently at a "very early stage," CFO Santhanam Subramanian confirmed exclusively to CNBC-TV18 on Thursday, August 21.

Subramanian said that while Zentiva fits into Aurobindo Pharma's strategic plans as it is based out of Europe, it is too premature to comment on a possible outcome due to the early stages of the discussion. The Aurobindo CFO did highlight that in case a deal fructifies, the announcement can be made in the next two months.

Aurobindo Pharma's shares fell 4% on Wednesday after reports indicated that the company is set to acquire Zentiva at a price between $5 billion to $5.5 billion. In response to that ET report, Aurobindo replied to the exchanges that they keep pursuing growth opportunities and will make appropriate announcements as and when such a situation arises.

This is a developing story and will be updated with more.Continue ReadingCheck out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!TagsAurobindo Pharmashare market today